Your browser doesn't support javascript.
loading
The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens.
Havrilesky, Laura J; Scott, Amelia L; Davidson, Brittany A; Secord, Angeles Alvarez; Yang, Jui-Chen; Johnson, F Reed; Gonzalez, Juan Marcos; Reed, Shelby D.
Affiliation
  • Havrilesky LJ; Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, United States of America; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, United States of America; Duke Cancer Institute, Duke University Medical Center, Durham, NC, United States of A
  • Scott AL; Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, United States of America.
  • Davidson BA; Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, United States of America; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, United States of America; Duke Cancer Institute, Duke University Medical Center, Durham, NC, United States of A
  • Secord AA; Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, United States of America; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, United States of America; Duke Cancer Institute, Duke University Medical Center, Durham, NC, United States of A
  • Yang JC; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States of America.
  • Johnson FR; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States of America; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States of America.
  • Gonzalez JM; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States of America; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States of America.
  • Reed SD; Duke Cancer Institute, Duke University Medical Center, Durham, NC, United States of America; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States of America; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United St
Gynecol Oncol ; 162(2): 440-446, 2021 08.
Article in En | MEDLINE | ID: mdl-34053748
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Patient Preference / Neoplasm Recurrence, Local Type of study: Diagnostic_studies / Etiology_studies / Observational_studies Aspects: Patient_preference Language: En Journal: Gynecol Oncol Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Patient Preference / Neoplasm Recurrence, Local Type of study: Diagnostic_studies / Etiology_studies / Observational_studies Aspects: Patient_preference Language: En Journal: Gynecol Oncol Year: 2021 Document type: Article